|
Volumn 32, Issue 8, 2014, Pages 774-782
|
Extent of resection of glioblastoma revisited: Personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
GADOLINIUM;
TEMOZOLOMIDE;
ACCELERATED FAILURE TIME;
ADJUVANT CHEMORADIOTHERAPY;
ADULT;
AGE;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CANCER PROGNOSIS;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CANCER SURVIVAL;
CONTRAST ENHANCEMENT;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC TEST ACCURACY STUDY;
EXTENT OF RESECTION;
FEMALE;
GLIOBLASTOMA;
HUMAN;
KARNOFSKY PERFORMANCE STATUS;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL PARAMETERS;
MULTIMODALITY CANCER THERAPY;
NEUROIMAGING;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATIENT SAFETY;
PERSONALIZED SURVIVAL PREDICTION;
PRIORITY JOURNAL;
SURVIVAL PREDICTION;
SURVIVAL RATE;
TIME;
BRAIN TUMOR;
COMPARATIVE STUDY;
DECISION SUPPORT SYSTEM;
MIDDLE AGED;
MINIMAL RESIDUAL DISEASE;
MORTALITY;
MULTICENTER STUDY;
MULTIVARIATE ANALYSIS;
NONLINEAR SYSTEM;
PATHOLOGY;
PATIENT SELECTION;
PERSONALIZED MEDICINE;
PREDICTIVE VALUE;
REPRODUCIBILITY;
RISK FACTOR;
SURVIVAL;
TREATMENT OUTCOME;
UNITED STATES;
VALIDATION STUDY;
VERY ELDERLY;
YOUNG ADULT;
ADULT;
AGED;
AGED, 80 AND OVER;
BRAIN NEOPLASMS;
CHEMORADIOTHERAPY, ADJUVANT;
DECISION SUPPORT TECHNIQUES;
FEMALE;
GLIOBLASTOMA;
HUMANS;
INDIVIDUALIZED MEDICINE;
KARNOFSKY PERFORMANCE STATUS;
MALE;
MIDDLE AGED;
MULTIVARIATE ANALYSIS;
NEOPLASM, RESIDUAL;
NONLINEAR DYNAMICS;
OHIO;
PATIENT SELECTION;
PREDICTIVE VALUE OF TESTS;
REPRODUCIBILITY OF RESULTS;
RISK FACTORS;
SURVIVAL ANALYSIS;
TEXAS;
TIME FACTORS;
TREATMENT OUTCOME;
YOUNG ADULT;
|
EID: 84899627936
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2013.51.8886 Document Type: Article |
Times cited : (258)
|
References (13)
|